Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Zoller

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
The Journal of Antimicrobial Chemotherapy|May 26, 2017
Optimization of linezolid therapy in the critically ill: the effect of adjusted infusion regimensMax Taubert, Johannes Zander, Sebastian Frechen, et al.
Journal of Intensive Care|December 9, 2020
The higher the better? Defining the optimal beta-lactam target for critically ill patients to reach infection resolution and improve outcomeChristina Scharf, Uwe Liebchen, Michael Paal, et al.
Journal of Critical Care|October 10, 2021
Trough concentrations of meropenem and piperacillin during slow extended dialysis in critically ill patients with intermittent and continuous infusion: A prospective observational studyUwe Liebchen, Michael Paal, Veronika Bucher, et al.
Antibiotics (Basel, Switzerland)|April 5, 2020
Therapeutic Drug Monitoring of Meropenem and Piperacillin in Critical Illness-Experience and Recommendations from One Year in Routine Clinical PracticeChristina Scharf, Michael Paal, Ines Schroeder, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2018
Ciprofloxacin in critically ill subjects: considering hepatic function, age and sex to choose the optimal doseXia Li, Michael Zoller, Uwe Fuhr, et al.
Annals of Intensive Care|June 21, 2024
Myoglobin adsorption and saturation kinetics of the cytokine adsorber Cytosorb® in patients with severe rhabdomyolysis: a prospective trialHelen Graf, Caroline Gräfe, Mathias Bruegel, et al.
Biomedicines|November 27, 2024
Angiopoietin II in Critically Ill Septic Patients: A Post Hoc Analysis of the DRAK StudyVeronika Bucher, Helen Graf, Johannes Zander, et al.
Journal of Critical Care|July 3, 2022
Serum linezolid concentrations are reduced in critically ill patients with pulmonary infections: A prospective observational studyMichael Zoller, Michael Paal, Antonia Greimel, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2021
Combination of Pharmacokinetic and Pathogen Susceptibility Information To Optimize Meropenem Treatment of Gram-Negative Infections in Critically Ill PatientsUwe Liebchen, Ferdinand Weinelt, Christina Scharf, et al.
Pharmaceutics|September 23, 2022
Systematic Evaluation of Voriconazole Pharmacokinetic Models without Pharmacogenetic Information for Bayesian Forecasting in Critically Ill PatientsSimon Kallee, Christina Scharf, Lea Marie Schatz, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
The Journal of Antimicrobial Chemotherapy|May 26, 2017
Optimization of linezolid therapy in the critically ill: the effect of adjusted infusion regimensMax Taubert, Johannes Zander, Sebastian Frechen, et al.
Journal of Intensive Care|December 9, 2020
The higher the better? Defining the optimal beta-lactam target for critically ill patients to reach infection resolution and improve outcomeChristina Scharf, Uwe Liebchen, Michael Paal, et al.
Journal of Critical Care|October 10, 2021
Trough concentrations of meropenem and piperacillin during slow extended dialysis in critically ill patients with intermittent and continuous infusion: A prospective observational studyUwe Liebchen, Michael Paal, Veronika Bucher, et al.
Antibiotics (Basel, Switzerland)|April 5, 2020
Therapeutic Drug Monitoring of Meropenem and Piperacillin in Critical Illness-Experience and Recommendations from One Year in Routine Clinical PracticeChristina Scharf, Michael Paal, Ines Schroeder, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2018
Ciprofloxacin in critically ill subjects: considering hepatic function, age and sex to choose the optimal doseXia Li, Michael Zoller, Uwe Fuhr, et al.
Annals of Intensive Care|June 21, 2024
Myoglobin adsorption and saturation kinetics of the cytokine adsorber Cytosorb® in patients with severe rhabdomyolysis: a prospective trialHelen Graf, Caroline Gräfe, Mathias Bruegel, et al.
Biomedicines|November 27, 2024
Angiopoietin II in Critically Ill Septic Patients: A Post Hoc Analysis of the DRAK StudyVeronika Bucher, Helen Graf, Johannes Zander, et al.
Journal of Critical Care|July 3, 2022
Serum linezolid concentrations are reduced in critically ill patients with pulmonary infections: A prospective observational studyMichael Zoller, Michael Paal, Antonia Greimel, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2021
Combination of Pharmacokinetic and Pathogen Susceptibility Information To Optimize Meropenem Treatment of Gram-Negative Infections in Critically Ill PatientsUwe Liebchen, Ferdinand Weinelt, Christina Scharf, et al.
Pharmaceutics|September 23, 2022
Systematic Evaluation of Voriconazole Pharmacokinetic Models without Pharmacogenetic Information for Bayesian Forecasting in Critically Ill PatientsSimon Kallee, Christina Scharf, Lea Marie Schatz, et al.
Pageof 9